Literature DB >> 3257965

Alpha 1-proteinase inhibitor is a neutrophil chemoattractant after proteolytic inactivation by macrophage elastase.

M J Banda1, A G Rice, G L Griffin, R M Senior.   

Abstract

Mouse macrophage elastase, a metalloproteinase, catalytically inactivates human alpha 1-proteinase inhibitor (alpha 1-PI) by attacking a single peptide bond between Pro357 and Met358, resulting in Mr = 4,200 and 47,800 fragments. We show here that this proteolytically inactivated alpha 1-PI is a potent chemotactic factor for human neutrophils at a concentration of 1 nM. The chemotactic response is equivalent to that elicited by formyl-methionyl-leucyl-phenylalanine. Native alpha 1-PI does not stimulate chemotaxis. Purification of the two fragments of alpha 1-PI that result from proteolysis by macrophage elastase indicated that the Mr = 4,200 fragment is responsible for the chemotactic activity. However, the two proteolysis fragments do not dissociate from each other under physiologic conditions. Therefore, the ability of proteolytically inactivated alpha 1-PI to act as a mediator of inflammation is due to rearrangement of the alpha 1-PI molecule rather than to release of a cleavage fragment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3257965

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

Review 1.  How matrix metalloproteinases regulate cell behavior.

Authors:  M D Sternlicht; Z Werb
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

2.  S-glutathionylated serine proteinase inhibitors as plasma biomarkers in assessing response to redox-modulating drugs.

Authors:  Christina L Grek; Danyelle M Townsend; Joachim D Uys; Yefim Manevich; Woodrow J Coker; Christopher J Pazoles; Kenneth D Tew
Journal:  Cancer Res       Date:  2012-03-08       Impact factor: 12.701

Review 3.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 4.  Proteinases and oxidants as targets in the treatment of chronic obstructive pulmonary disease.

Authors:  Caroline A Owen
Journal:  Proc Am Thorac Soc       Date:  2005

5.  Interstitial collagenase (matrix metalloproteinase-1) expresses serpinase activity.

Authors:  P E Desrochers; J J Jeffrey; S J Weiss
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

6.  Chemoattractant activity of Staphylococcus aureus serine proteinase modified human plasma alpha-1-proteinase inhibitor.

Authors:  K Baran; M Górka; J Potempa; Z Porwit-Bóbr
Journal:  Antonie Van Leeuwenhoek       Date:  1989-11       Impact factor: 2.271

7.  Solution structure of inhibitor-free human metalloelastase (MMP-12) indicates an internal conformational adjustment.

Authors:  Rajagopalan Bhaskaran; Mark O Palmier; Nusayba A Bagegni; Xiangyang Liang; Steven R Van Doren
Journal:  J Mol Biol       Date:  2007-10-16       Impact factor: 5.469

8.  Effects of serine protease inhibitors on accumulation of polymorphonuclear leukocytes in the lung induced by acute pancreatitis in rats.

Authors:  Y Okumura; H Inoue; Y Fujiyama; T Bamba
Journal:  J Gastroenterol       Date:  1995-06       Impact factor: 7.527

9.  Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages.

Authors:  R C Hubbard; G Fells; J Gadek; S Pacholok; J Humes; R G Crystal
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

10.  The serpin-enzyme complex (SEC) receptor mediates the neutrophil chemotactic effect of alpha-1 antitrypsin-elastase complexes and amyloid-beta peptide.

Authors:  G Joslin; G L Griffin; A M August; S Adams; R J Fallon; R M Senior; D H Perlmutter
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.